Decoding Neurology.
In the blink of AI.

  • Harvard University
  • Cambridge University
  • Imperial Collage London
  • King's Collage London
  • University College London
  • National Health Service
We develop proprietary ocular biomarkers to revolutionise neurology care and drug development.

Ocular biomarker AI engine

We develop proprietary ocular biomarkers to revolutionise neurology care and drug development. Our collaborations with world-leading clinical and research organisations1  enable us to create state-of-the-art digital biomarker capture and analytics products.

[1]: University of Oxford, University College London Hospitals, Guy's and St Thomas' Hospital, Queen Mary University

Get early access to our technology.

Request a demo
PatientsClinicsPharma

Frontier of neurological care

Solvemed works with patients, healthcare providers and life sciences industry to establish the next level of care for people suffering from neurodegenerative disorders.

LinkedIn News

info@solvemed.ai  +44 7857 823 182
© 2021 Solvemed Group • Cambridge, UK
  • Sunfish Partners
  • Rheingau
  • Panacea Stars
  • The BioIndustry Association
  • Barclays
  • NVIDIA
  • Polish Development Fund